Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03688945 · ClinicalTrials.gov registry record · NA

Art in Improving Outcomes in Participants Undergo Surgery

A NA study, sponsored by Roswell Park Cancer Institute.

Terminated
Registry status
NA
Development phase
80
Enrollment target

NCT03688945: Clinical Trial NA study, sponsored by Roswell Park Cancer Institute.

NCT03688945 is a NA study that was terminated before completion, run by Roswell Park Cancer Institute. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03688945, a NA study, was terminated before completion, sponsored by Roswell Park Cancer Institute.

TERMINATED
Registry status
NA
Development phase
80 participants
Enrollment target

Study Summary

This trial studies how well art works in improving outcomes in participants who are undergoing surgery. Exposure to art may help to improve clinical and psychological outcomes.

Primary Outcome

Will be assessed by using a Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS). This is a 14 item scale with 5 response categories that cover both feeling and functioning aspects of mental wellbeing.

Interventions

  • OTHER Questionnaire Administration
  • OTHER Best Practice
  • PROCEDURE Art Therapy

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2017-08-07
Est. Completion 2019-11-27
Phase NA
Roswell Park Cancer Institute

365 total trials

Why NCT03688945 stopped before completion

NCT03688945 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 3 interventions - of which Questionnaire Administration is the first listed.

NCT03688945 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03688945 about?

NCT03688945 is a clinical study titled "Art in Improving Outcomes in Participants Undergo Surgery". This trial studies how well art works in improving outcomes in participants who are undergoing surgery. Exposure to art may help to improve clinical and psychological outcomes.

What is the current status of trial NCT03688945?

This trial is currently terminated. It is a NA study. The enrollment target is 80 participants. The study started on 2017-08-07. Estimated completion is 2019-11-27.

What interventions are being tested in trial NCT03688945?

The interventions under investigation include: Questionnaire Administration (OTHER), Best Practice (OTHER), Art Therapy (PROCEDURE).

Who is sponsoring clinical trial NCT03688945?

This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03688945's enrollment target sits among peer trials

80 994th of 2000 higher than 941 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03688945, the US trial registry maintained by the National Library of Medicine. NCT03688945 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.